Table 3 Outcomes of NKF and TPS groups
TPS(n = 31) | NKF(n = 47) | p | |
|---|---|---|---|
Post-ERCP amylase level > 3 ULN, n(%) | 9 (29.0) | 5 (11.9) | 0.07 |
Post-ERCP lipase level > 3 ULN, n(%) | 13 (41.9) | 11 (25.0) | 0.14 |
Post-ERCP amylase level, median (IQR) | 155 (260) | 62 (103) | 0.01 |
Post-ERCP lipase level, median (IQR) | 148 (590) | 97 (209.5) | 0.21 |
PEP, n (%) | 5 (16.1) | 3 (6.4) | 0.17 |
Mild | 5 (16.1) | 3(6.4) | |
Moderate | 0 (0) | 0 (0) | |
Severe | 0 (0) | 0 (0) | |
Bleeding, n (%) | |||
All bleeding | 1 (3.2) | 4 (8.5) | 0.35 |
Significant bleeding | 1 (3.2) | 1 (2.1) | 0.76 |
Acute cholangitis, n (%) | 0 (0) | 2 (4.3) | 0.25 |
Perforation, n (%) | 0 (0) | 0 (0) | |
Total complication events (endoscopically bleeding + perforation + PEP + cholangitis), n (%) | 6 (19.3) | 9 (19.1) | 0.99 |
Total complication events (significant bleeding + perforation + PEP + cholangitis), n (%) | 6 (19.3) | 6 (12.8) | 0.51 |